Inflammatory bowel disease in Korea: epidemiology and pathophysiology

키워드

참고문헌 (84)

1. Jong Pil Im, "Changing treatment paradigms for the management of inflammatory bowel disease", The Korean Journal of Internal Medicine, 33(1), pp.28~35 (2018), 대한내과학회[DOI]
2. Hyo Sun Lee, "Novel treatments for inflammatory bowel disease", The Korean Journal of Internal Medicine, 33(1), pp.20~27 (2018), 대한내과학회[DOI]
3. Jooyoung Lee, "Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study", Gut and Liver, 14(1), pp.89~99 (2020), 거트앤리버 소화기연관학회협의회
4. Kim JW, "Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea : a nationwide population-based study", J Gastroenterol Hepatol, 33, pp.847~854 (2018)
5. Hsu-Heng Yen, "Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study", Intestinal research, 17(1), pp.54~62 (2019), 대한장연구학회[DOI]
6. Park SH, "A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015", J Crohns Colitis, 13, pp.1410~1417 (2019)
7. Cha JM, "Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea", Gut, 69, pp.1432~1440 (2020)
8. 천재희, "Crohn’s Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn’s Disease in Korea", Intestinal research, 12(3), pp.173~175 (2014), 대한장연구학회
9. Jung Won Lee, "Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future", Intestinal research, 13(3), pp.213~218 (2015), 대한장연구학회
10. Moon CM, "Clinical factors and disease course related to diagnostic delay in Korean Crohn’s disease patients : results from the CONNECT Study", PLoS One, 10, pp.e0144390~ (2015)
11. Ye Byong Duk, "Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study", Gut and Liver, 16(2), pp.216~227 (2022), 거트앤리버 소화기연관학회협의회[DOI]
12. Yoon JY, "Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea : results from a hospital-based inception cohort study(MOSAIK)", J Gastroenterol Hepatol, 36, pp.2149~2156 (2021)
13. 윤준식, "Quality of information on the Internet for Korean patients with inflammatory bowel disease", The Korean Journal of Internal Medicine, 34(6), pp.1215~1222 (2019), 대한내과학회[DOI]
14. 박지혜, "Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management", The Korean Journal of Internal Medicine, 36(5), pp.1040~1048 (2021), 대한내과학회[DOI]
15. 홍승욱, "The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia", Intestinal research, 18(4), pp.345~346 (2020), 대한장연구학회[DOI]
16. 송은미, "Natural history of inflammatory bowel disease: a comparison between the East and the West", Intestinal research, 20(4), pp.418~430 (2022), 대한장연구학회[DOI]
17. Kaplan GG, "The four epidemiological stages in the global evolution of inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 18, pp.56~66 (2021)
18. Satimai Aniwan, "Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018", Intestinal research, 19(2), pp.186~193 (2021), 대한장연구학회[DOI]
19. Jamilya Kaibullayeva, "Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study", Intestinal research, 18(4), pp.430~437 (2020), 대한장연구학회[DOI]
20. Ajit Sood, "Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry", Intestinal research, 19(2), pp.206~216 (2021), 대한장연구학회[DOI]
21. Kwak MS, "Emerging trends of inflammatory bowel disease in South Korea : a nationwide population-based study", J Gastroenterol Hepatol, 34, pp.1018~1026 (2019)
22. "2020Inflammatory bowel disease fact sheet in Korea" (2020)[URL]
23. Lee CK, "Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database", J Gastroenterol Hepatol, 35, pp.760~768 (2020)
24. Shah SC, "Sex-based differences in incidence of inflammatory bowel diseases : pooled analysis of population-based studies from Western countries", Gastroenterology, 155, pp.1079~1089 (2018)
25. Jeongseok Kim, "Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?", Intestinal research, 17(1), pp.24~35 (2019), 대한장연구학회[DOI]
26. Banerjee Rupa, "Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease", Intestinal research, 19(4), pp.398~407 (2021), 대한장연구학회[DOI]
27. Park SH, "Clinical features and long-term outcomes of paediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea", J Crohns Colitis, 16, pp.207~215 (2022)
28. Singh S, "Management of inflammatory bowel diseases in special populations : obese, old, or obstetric", Clin Gastroenterol Hepatol, 18, pp.1367~1380 (2020)
29. Shi HY, "Natural history of elderly-onset ulcerative colitis : results from a Territory-wide Inflammatory Bowel Disease Registry", J Crohns Colitis, 10, pp.176~185 (2016)
30. Park Sang Hyoung, "Clinical Characteristics and Long-term Prognosis of Elderly-Onset Ulcerative Colitis in a Population-Based Cohort in the Songpa- Kangdong District of Seoul, Korea", Gut and Liver, 15(5), pp.742~751 (2021), 거트앤리버 소화기연관학회협의회[DOI]
31. Song EM, "Clinical characteristics and long-term prognosis of elderly onset ulcerative colitis", J Gastroenterol Hepatol, 33, pp.172~179 (2018)
32. Hwang SW, "Influence of a positive family history on the clinical course of inflammatory bowel disease", J Crohns Colitis, 10, pp.1024~1032 (2016)
33. Jung YS, "Long-term clinical outcomes of urban versus rural environment in Korean patients with Crohn’s disease : results from the CONNECT study", J Crohns Colitis, 9, pp.246~251 (2015)
34. Choe JY, "Incidence and prevalence trends of pediatric inflammatory bowel disease in the Daegu-Kyungpook province from 2017 to 2020", Front Pediatr, 9, pp.810173~ (2022)
35. 이은지, "Clinical features of Crohn’s disease in Korean patients residing in Busan and Gyeongnam", Intestinal research, 14(1), pp.30~36 (2016), 대한장연구학회
36. Han M, "Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases", J Gastroenterol Hepatol, 34, pp.1166~1174 (2019)
37. Julajak Limsrivilai, "Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases", Intestinal research, 19(1), pp.21~32 (2021), 대한장연구학회[DOI]
38. Ho-Su Lee, "Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea", Intestinal research, 14(3), pp.258~263 (2016), 대한장연구학회
39. Rupa Banerjee, "Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries", Gut and Liver, 14(6), pp.685~698 (2020), 거트앤리버 소화기연관학회협의회[DOI]
40. Hee Seung Hong, "Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases", The Korean Journal of Internal Medicine, 37(1), pp.73~84 (2022), 대한내과학회[DOI]
41. Park SH, "Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases", Inflamm Bowel Dis, 18, pp.2004~2010 (2012)
42. Soo-Kyung Park, "Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 18(1), pp.18~33 (2020), 대한장연구학회
43. Lee HS, "Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis", Inflamm Bowel Dis, 22, pp.912~918 (2016)
44. Park SH, "Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis", Dig Dis Sci, 58, pp.3592~3599 (2013)
45. Tsai L, "Epidemiology and natural history of perianal Crohn’s disease : a systematic review and meta-analysis of population-based cohorts", Inflamm Bowel Dis (2021)[DOI]
46. Jaeyoung Chun, "Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study", Gut and Liver, 12(5), pp.544~554 (2018), 거트앤리버 소화기연관학회협의회
47. Ye BD, "Clinical features and long-term prognosis of Crohn’s disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)
48. Jin Young Yoon, "Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years", Gut and Liver, 12(3), pp.297~305 (2018), 거트앤리버 소화기연관학회협의회
49. 김정민, "Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases", Intestinal research, 18(3), pp.249~264 (2020), 대한장연구학회[DOI]
50. 하유정, "Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn’s disease", The Korean Journal of Internal Medicine, 36(4), pp.868~877 (2021), 대한내과학회[DOI]
51. Yang BR, "Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients", PLoS One, 13, pp.e0200363~ (2018)
52. Graham DB, "Pathway paradigms revealed from the genetics of inflammatory bowel disease", Nature, 578, pp.527~539 (2020)
53. Chen CJ, "Pathophysiology of inflammatory bowel diseases", N Engl J Med, 384, pp.1376~1377 (2021)
54. Mitsialis V, "Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease", Gastroenterology, 159, pp.591~608 (2020)
55. Hong SN, "Deep resequencing of 131Crohn’s disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants", Gut, 65, pp.788~796 (2016)
56. Cadwell K, "Virus-plus-susceptibility gene interaction determines Crohn’s disease gene Atg16L1phenotypes in intestine", Cell, 141, pp.1135~1145 (2010)
57. Liu JZ, "Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations", Nat Genet, 47, pp.979~986 (2015)
58. Weiser M, "Molecular classification of Crohn’s disease reveals two clinically relevant subtypes", Gut, 67, pp.36~42 (2018)
59. Steven Nicolaides, "The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease", Intestinal research, 19(2), pp.158~170 (2021), 대한장연구학회[DOI]
60. Ng SC, "Environmental risk factors in inflammatory bowel disease : a population-based case-control study in Asia-Pacific", Gut, 64, pp.1063~1071 (2015)
61. Piovani D, "Environmental risk factors for inflammatory bowel diseases : an umbrella review of meta-analyses", Gastroenterology, 157, pp.647~659 (2019)
62. Roncoroni L, "Nutrition in patients with inflammatory bowel diseases : a narrative review", Nutrients, 14, pp.751~ (2022)
63. Levine A, "Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases", Gut, 67, pp.1726~1738 (2018)
64. Nor Hamizah Shafiee, "Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?", Intestinal research, 19(2), pp.171~185 (2021), 대한장연구학회[DOI]
65. Emiko Mizoguchi, "Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models", Intestinal research, 18(2), pp.151~167 (2020), 대한장연구학회[DOI]
66. Read E, "The role of oral bacteria in inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 18, pp.731~742 (2021)
67. Leiper K, "Randomised placebo-controlled trial of rituximab(anti-CD20)in active ulcerative colitis", Gut, 60, pp.1520~1526 (2011)
68. Park SC, "Anti-integrin therapy for inflammatory bowel disease", World J Gastroenterol, 24, pp.1868~1880 (2018)
69. Konstantinos H. Katsanos, "Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics", Gut and Liver, 11(4), pp.455~463 (2017), 거트앤리버 소화기연관학회협의회
70. Neurath MF, "Current and emerging therapeutic targets for IBD", Nat Rev Gastroenterol Hepatol, 14, pp.269~278 (2017)
71. Salas A, "JAK-STAT pathway targeting for the treatment of inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 17, pp.323~337 (2020)
72. Seung-Joo Nam, "T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn’s disease patients", Intestinal research, 16(1), pp.160~162 (2018), 대한장연구학회
73. Chang JT, "Molecular regulation of effector and memory T cell differentiation", Nat Immunol, 15, pp.1104~1115 (2014)
74. Ritika Rampal, "Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease", Intestinal research, 19(2), pp.232~238 (2021), 대한장연구학회[DOI]
75. Gaffen SL, "The IL-23-IL-17 immune axis : from mechanisms to therapeutic testing", Nat Rev Immunol, 14, pp.585~600 (2014)
76. Lee JW, "Novel histone deacetylase 6inhibitor CKD-506 inhibits NF-κB signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis", Inflamm Bowel Dis, 26, pp.852~862 (2020)
77. Caruso R, "Host-microbiota interactions in inflammatory bowel disease", Nat Rev Immunol, 20, pp.411~426 (2020)
78. Iliev ID, "Effects of intestinal fungi and viruses on immune responses and inflammatory bowel diseases", Gastroenterology, 160, pp.1050~1066 (2021)
79. 박찬혁, "Intestinal microbiota, chronic inflammation, and colorectal cancer", Intestinal research, 16(3), pp.338~345 (2018), 대한장연구학회
80. Park SK, "Differentially abundant bacterial taxa associated with prognostic variables of Crohn’s disease : results from the IMPACT Study", J Clin Med, 9, pp.1748~ (2020)
81. Kostic AD, "The microbiome in inflammatory bowel disease : current status and the future ahead", Gastroenterology, 146, pp.1489~1499 (2014)
82. Stephanie J King, "Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease", Intestinal research, 17(2), pp.177~191 (2019), 대한장연구학회[DOI]
83. Schirmer M, "Microbial genes and pathways in inflammatory bowel disease", Nat Rev Microbiol, 17, pp.497~511 (2019)
84. Mishima Y, "Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases", J Gastroenterol, 55, pp.4~14 (2020)

관련 논문AI추천